Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes: Study of Insulin Sensitivity in the 2 Types of Treatment
Latest Information Update: 26 Feb 2024
Price :
$35 *
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glulisine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TRICIDIA; TRICIDIA2
- 20 Feb 2024 Status changed from recruiting to discontinued.
- 20 Feb 2024 Status changed from recruiting to discontinued.
- 09 Sep 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov (NCT02048189)